| Year |
Citation |
Score |
| 2023 |
Streblow DN, Hirsch AJ, Stanton JJ, Lewis AD, Colgin L, Hessell AJ, Kreklywich CN, Smith JL, Sutton WF, Chauvin D, Woo J, Bimber BN, LeBlanc CN, Acharya SN, O'Roak BJ, ... ... Haigwood NL, et al. Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology. Nature Communications. 14: 7062. PMID 37923717 DOI: 10.1038/s41467-023-42440-x |
0.344 |
|
| 2023 |
Rosenberg YJ, Ordonez T, Khanwalkar US, Barnette P, Pandey S, Backes IM, Otero CE, Goldberg BS, Crowley AR, Leib DA, Shapiro MB, Jiang X, Urban LA, Lees J, Hessell AJ, ... ... Haigwood NL, et al. Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates. Mbio. e0034123. PMID 36946726 DOI: 10.1128/mbio.00341-23 |
0.312 |
|
| 2022 |
Weiss S, Itri V, Pan R, Jiang X, Luo CC, Morris L, Malherbe DC, Barnette P, Alexander J, Kong XP, Haigwood NL, Hessell AJ, Duerr R, Zolla-Pazner S. Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines. Nature Communications. 13: 903. PMID 35173151 DOI: 10.1038/s41467-022-28450-1 |
0.505 |
|
| 2022 |
Spencer DA, Goldberg BS, Pandey S, Ordonez T, Dufloo J, Barnette P, Sutton WF, Henderson H, Agnor R, Gao L, Bruel T, Schwartz O, Haigwood NL, Ackerman ME, Hessell AJ. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis. Nature Communications. 13: 662. PMID 35115533 DOI: 10.1038/s41467-022-28250-7 |
0.419 |
|
| 2021 |
Sarkar S, Spencer DA, Barnette P, Pandey S, Sutton WF, Basu M, Burch RE, Cleveland JD, Rosenberg AF, Rangel-Moreno J, Keefer MC, Hessell AJ, Haigwood NL, Kobie JJ. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques. Frontiers in Immunology. 12: 757811. PMID 34745131 DOI: 10.3389/fimmu.2021.757811 |
0.538 |
|
| 2021 |
Li L, Hessell AJ, Kong XP, Haigwood NL, Gorny MK. A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque. Vaccine. PMID 34400018 DOI: 10.1016/j.vaccine.2021.08.015 |
0.426 |
|
| 2021 |
Wen J, Cheever T, Wang L, Wu D, Reed J, Mascola J, Chen X, Liu C, Pegu A, Sacha JB, Lu Y, Haigwood NL, Chen ISY. Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques. Plos Pathogens. 17: e1009738. PMID 34283885 DOI: 10.1371/journal.ppat.1009738 |
0.33 |
|
| 2021 |
Rosenberg YJ, Jiang X, Cheever T, Coulter FJ, Pandey S, Sack M, Mao L, Urban L, Lees J, Fischer M, Smedley J, Sidener H, Stanton J, Haigwood NL. Protection of newborn macaques by plant-derived HIV broadly neutralizing antibodies: a model for passive immunotherapy during breastfeeding. Journal of Virology. JVI0026821. PMID 34190597 DOI: 10.1128/JVI.00268-21 |
0.483 |
|
| 2021 |
Spencer DA, Shapiro MB, Haigwood NL, Hessell AJ. Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic. Frontiers in Public Health. 9: 690017. PMID 34123998 DOI: 10.3389/fpubh.2021.690017 |
0.394 |
|
| 2021 |
Chang XL, Webb GM, Wu HL, Greene JM, Abdulhaqq S, Bateman KB, Reed JS, Pessoa C, Weber WC, Maier N, Chew GM, Gilbride RM, Gao L, Agnor R, Giobbi T, ... ... Haigwood NL, et al. Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission. Nature Communications. 12: 3343. PMID 34099693 DOI: 10.1038/s41467-021-23697-6 |
0.476 |
|
| 2021 |
Klatt NR, Broedlow C, Osborn JM, Gustin AT, Dross S, O'Connor MA, Coronado E, Barnette P, Hensley-McBain T, Zevin AS, Muir R, Roederer A, Wangari S, Iwayama N, Ahrens CY, ... ... Haigwood NL, et al. Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques. Npj Vaccines. 6: 34. PMID 33707443 DOI: 10.1038/s41541-021-00298-4 |
0.423 |
|
| 2021 |
Hessell AJ, Li L, Malherbe DC, Barnette P, Pandey S, Sutton W, Spencer D, Wang XH, Gach JS, Hunegnaw R, Tuen M, Jiang X, Luo CC, LaBranche CC, Shao Y, ... ... Haigwood NL, et al. Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone. Journal of Immunology (Baltimore, Md. : 1950). PMID 33536254 DOI: 10.4049/jimmunol.2001010 |
0.435 |
|
| 2021 |
Spencer DA, Malherbe DC, Vázquez Bernat N, Ádori M, Goldberg B, Dambrauskas N, Henderson H, Pandey S, Cheever T, Barnette P, Sutton WF, Ackerman ME, Kobie JJ, Sather DN, Karlsson Hedestam GB, ... Haigwood NL, et al. Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor. Journal of Immunology (Baltimore, Md. : 1950). PMID 33472907 DOI: 10.4049/jimmunol.2001082 |
0.552 |
|
| 2020 |
Malherbe DC, Vang L, Mendy J, Barnette PT, Spencer DA, Reed J, Kareko BW, Sather DN, Pandey S, Wibmer CK, Robins H, Fuller DH, Park B, Lakhashe SK, Wilson JM, ... ... Haigwood NL, et al. Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge. Frontiers in Immunology. 11: 626464. PMID 33658998 DOI: 10.3389/fimmu.2020.626464 |
0.404 |
|
| 2020 |
Malherbe DC, Wibmer CK, Nonyane M, Reed J, Sather DN, Spencer DA, Schuman JT, Guo B, Pandey S, Robins H, Park B, Fuller DH, Sacha JB, Moore PL, Hessell AJ, ... Haigwood NL, et al. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development. Frontiers in Immunology. 11: 984. PMID 32582155 DOI: 10.3389/Fimmu.2020.00984 |
0.587 |
|
| 2020 |
Powell RL, Weiss S, Fox A, Liu X, Itri V, Jiang X, Luo CC, Spencer DA, Pandey S, Cheever T, Fuller DH, Totrov M, Hessell AJ, Haigwood NL, Kong XP, et al. An HIV vaccine targeting the V2 region of Envelope induces a highly durable polyfunctional Fc-mediated antibody response in rhesus macaques. Journal of Virology. PMID 32554699 DOI: 10.1128/Jvi.01175-20 |
0.544 |
|
| 2020 |
Berendam SJ, Nelson AN, Goswami R, Persaud D, Haigwood NL, Chahroudi A, Fouda GG, Permar SR. Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure. Current Hiv/Aids Reports. PMID 32356090 DOI: 10.1007/S11904-020-00495-1 |
0.487 |
|
| 2020 |
Gary E, O'Connor M, Chakhtoura M, Tardif V, Kumova OK, Malherbe DC, Sutton WF, Haigwood NL, Kutzler MA, Haddad EK. Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines. Vaccine. PMID 32280045 DOI: 10.1016/J.Vaccine.2020.03.047 |
0.549 |
|
| 2020 |
Shapiro MB, Cheever T, Malherbe DC, Pandey S, Reed J, Yang ES, Wang K, Pegu A, Chen X, Siess D, Burke D, Henderson H, Lewinsohn R, Fischer M, Stanton JJ, ... ... Haigwood NL, et al. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity. Nature Communications. 11: 70. PMID 31911610 DOI: 10.1038/s41467-019-13972-y |
0.389 |
|
| 2019 |
Pegu A, Borate B, Huang Y, Pauthner MG, Hessell AJ, Julg B, Doria-Rose NA, Schmidt SD, Carpp LN, Cully MD, Chen X, Shaw GM, Barouch DH, Haigwood NL, Corey L, et al. A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. Cell Host & Microbe. 26: 336-346.e3. PMID 31513771 DOI: 10.1016/J.Chom.2019.08.014 |
0.553 |
|
| 2019 |
Hessell AJ, Powell R, Jiang X, Luo C, Weiss S, Dussupt V, Itri V, Fox A, Shapiro MB, Pandey S, Cheever T, Fuller DH, Park B, Krebs SJ, Totrov M, ... Haigwood NL, et al. Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses. Cell Reports. 28: 877-895.e6. PMID 31340151 DOI: 10.1016/J.Celrep.2019.06.074 |
0.612 |
|
| 2019 |
Bar KJ, Coronado E, Hensley-McBain T, O'Connor MA, Osborn JM, Miller C, Gott TM, Wangari S, Iwayama N, Ahrens CY, Smedley J, Moats C, Lynch RM, Haddad EK, Haigwood NL, et al. SHIV.CH505 infection of rhesus macaques results in persistent viral replication and induces intestinal immunopathology. Journal of Virology. PMID 31217249 DOI: 10.1128/Jvi.00372-19 |
0.516 |
|
| 2019 |
Nikzad R, Angelo LS, Aviles-Padilla K, Le DT, Singh VK, Bimler L, Vukmanovic-Stejic M, Vendrame E, Ranganath T, Simpson L, Haigwood NL, Blish CA, Akbar AN, Paust S. Human natural killer cells mediate adaptive immunity to viral antigens. Science Immunology. 4. PMID 31076527 DOI: 10.1126/Sciimmunol.Aat8116 |
0.427 |
|
| 2019 |
Haigwood NL, Hessell AJ. Antibodies Tip the Balance Towards an HIV Cure. Trends in Immunology. 40: 375-377. PMID 31030743 DOI: 10.1016/J.It.2019.03.008 |
0.576 |
|
| 2019 |
Sarkar S, Piepenbrink MS, Basu M, Thakar J, Keefer MC, Hessell AJ, Haigwood NL, Kobie JJ. IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine. Vaccine. PMID 30926296 DOI: 10.1016/J.Vaccine.2019.03.044 |
0.518 |
|
| 2019 |
Matchett WE, Anguiano-Zarate SS, Nehete PN, Shelton K, Nehete BP, Yang G, Dorta-Estremera S, Barnette P, Xiao P, Byrareddy SN, Villinger F, Hessell AJ, Haigwood NL, Sastry KJ, Barry MA. Divergent HIV-1 Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques. Journal of Virology. PMID 30842321 DOI: 10.1128/Jvi.02016-18 |
0.555 |
|
| 2018 |
Chukwuma VU, Kose N, Sather DN, Sapparapu G, Falk R, King H, Singh V, Lampley R, Malherbe DC, Ditto NT, Sullivan JT, Barnes T, Doranz BJ, Labranche CC, Montefiori DC, ... ... Haigwood NL, et al. Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. Plos One. 13: e0209437. PMID 30566528 DOI: 10.1371/Journal.Pone.0209437 |
0.616 |
|
| 2018 |
Haigwood NL. Antibodies pose a double threat to HIV. Nature. 561: 468-470. PMID 30258147 DOI: 10.1038/D41586-018-06773-8 |
0.527 |
|
| 2018 |
Hessell AJ, Shapiro MB, Powell R, Malherbe DC, McBurney SP, Pandey S, Cheever T, Sutton WF, Kahl C, Park B, Zolla-Pazner S, Haigwood NL. Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges. Journal of Virology. PMID 29514914 DOI: 10.1128/Jvi.02198-17 |
0.602 |
|
| 2018 |
Balasubramanian P, Williams C, Shapiro MB, Sinangil F, Higgins K, Nádas A, Totrov M, Kong XP, Fiore-Gartland AJ, Haigwood NL, Zolla-Pazner S, Hioe CE. Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials. Scientific Reports. 8: 542. PMID 29323175 DOI: 10.1038/S41598-017-18863-0 |
0.54 |
|
| 2018 |
Hessell AJ, Malherbe DC, Haigwood NL. Passive and active antibody studies in primates to inform HIV vaccines. Expert Review of Vaccines. PMID 29307225 DOI: 10.1080/14760584.2018.1425619 |
0.595 |
|
| 2017 |
Burwitz BJ, Wettengel JM, Mück-Häusl MA, Ringelhan M, Ko C, Festag MM, Hammond KB, Northrup M, Bimber BN, Jacob T, Reed JS, Norris R, Park B, Moller-Tank S, Esser K, ... ... Haigwood NL, et al. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques. Nature Communications. 8: 2146. PMID 29247188 DOI: 10.1038/S41467-017-01953-Y |
0.378 |
|
| 2017 |
Malherbe DC, Mendy J, Vang L, Barnette PT, Reed J, Lakhashe SK, Owuor J, Gach JS, Legasse AW, Axthelm MK, LaBranche CC, Montefiori D, Forthal DN, Park B, Wilson JM, ... ... Haigwood NL, et al. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge. Journal of Virology. PMID 29093095 DOI: 10.1128/Jvi.01092-17 |
0.505 |
|
| 2017 |
Jaworski JP, Bryk P, Brower Z, Zheng B, Hessell AJ, Rosenberg AF, Wu TT, Sanz I, Keefer MC, Haigwood NL, Kobie JJ. Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques. Plos One. 12: e0172524. PMID 28222180 DOI: 10.1371/Journal.Pone.0172524 |
0.524 |
|
| 2017 |
Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, et al. Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination. Vaccine. PMID 28185743 DOI: 10.1016/J.Vaccine.2016.11.107 |
0.581 |
|
| 2017 |
Pegu A, Hessell AJ, Mascola JR, Haigwood NL. Use of broadly neutralizing antibodies for HIV-1 prevention. Immunological Reviews. 275: 296-312. PMID 28133803 DOI: 10.1111/Imr.12511 |
0.545 |
|
| 2016 |
Trovato M, Maurano F, D'Apice L, Costa V, Sartorius R, Cuccaro F, McBurney SP, Krebs SJ, Prisco A, Ciccodicola A, Rossi M, Haigwood NL, De Berardinis P. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. Bmc Microbiology. 16: 152. PMID 27421762 DOI: 10.1186/S12866-016-0772-X |
0.406 |
|
| 2016 |
Hessell AJ, McBurney S, Pandey S, Sutton W, Liu L, Li L, Totrov M, Zolla-Pazner S, Haigwood NL, Gorny MK. Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides. Vaccine. PMID 27102818 DOI: 10.1016/J.Vaccine.2016.04.027 |
0.508 |
|
| 2016 |
McBurney SP, Sunshine JE, Gabriel S, Huynh JP, Sutton WF, Fuller DH, Haigwood NL, Messer WB. Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine. PMID 27085173 DOI: 10.1016/J.Vaccine.2016.03.108 |
0.446 |
|
| 2016 |
Hessell AJ, Jaworski JP, Epson E, Matsuda K, Pandey S, Kahl C, Reed J, Sutton WF, Hammond KB, Cheever TA, Barnette PT, Legasse AW, Planer S, Stanton JJ, Pegu A, ... ... Haigwood NL, et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nature Medicine. PMID 26998834 DOI: 10.1038/Nm.4063 |
0.537 |
|
| 2016 |
Hessell AJ, Malherbe DC, Pissani F, McBurney S, Krebs SJ, Gomes M, Pandey S, Sutton WF, Burwitz BJ, Gray M, Robins H, Park BS, Sacha JB, LaBranche CC, Fuller DH, ... ... Haigwood NL, et al. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens. Journal of Immunology (Baltimore, Md. : 1950). PMID 26944928 DOI: 10.4049/Jimmunol.1500527 |
0.597 |
|
| 2016 |
Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell A, Higgins K, Liu L, Haigwood N, Sinangil F, Gorny M, Totrov M, Kong X, Nadas A, Zolla-Pazner S, et al. P-C16 Differential Induction of Anti-V3 Crown Antibodies with Cradle and Ladle-Binding Modes in Response to HIV-1 Envelope Vaccination Journal of Acquired Immune Deficiency Syndromes. 71: 84. DOI: 10.1097/01.Qai.0000479635.49430.16 |
0.515 |
|
| 2015 |
Kobie JJ, Zheng B, Piepenbrink MS, Hessell AJ, Haigwood NL, Keefer MC, Sanz I. Functional and Molecular Characteristics of Novel and Conserved Cross-Clade HIV Envelope Specific Human Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 34: 65-72. PMID 25897603 DOI: 10.1089/Mab.2014.0064 |
0.616 |
|
| 2015 |
Hessell AJ, Haigwood NL. Animal models in HIV-1 protection and therapy. Current Opinion in Hiv and Aids. 10: 170-6. PMID 25730345 DOI: 10.1097/Coh.0000000000000152 |
0.436 |
|
| 2015 |
Haigwood NL. HIV: tied down by its own receptor. Nature. 519: 36-7. PMID 25707798 DOI: 10.1038/Nature14205 |
0.549 |
|
| 2014 |
Krebs SJ, McBurney SP, Kovarik DN, Waddell CD, Jaworski JP, Sutton WF, Gomes MM, Trovato M, Waagmeester G, Barnett SJ, DeBerardinis P, Haigwood NL. Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA. Plos One. 9: e113463. PMID 25514675 DOI: 10.1371/Journal.Pone.0113463 |
0.801 |
|
| 2014 |
Malherbe DC, Pissani F, Sather DN, Guo B, Pandey S, Sutton WF, Stuart AB, Robins H, Park B, Krebs SJ, Schuman JT, Kalams S, Hessell AJ, Haigwood NL. Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits. Journal of Virology. 88: 12949-67. PMID 25210191 DOI: 10.1128/Jvi.01812-14 |
0.624 |
|
| 2014 |
Sather DN, Carbonetti S, Malherbe DC, Pissani F, Stuart AB, Hessell AJ, Gray MD, Mikell I, Kalams SA, Haigwood NL, Stamatatos L. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1. Journal of Virology. 88: 12968-81. PMID 25122781 DOI: 10.1128/Jvi.01816-14 |
0.562 |
|
| 2014 |
Ma Y, Tao W, Krebs SJ, Sutton WF, Haigwood NL, Gill HS. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharmaceutical Research. 31: 2393-403. PMID 24623480 DOI: 10.1007/S11095-014-1335-1 |
0.324 |
|
| 2014 |
Pissani F, Malherbe DC, Schuman JT, Robins H, Park BS, Krebs SJ, Barnett SW, Haigwood NL. Improvement of antibody responses by HIV envelope DNA and protein co-immunization. Vaccine. 32: 507-13. PMID 24280279 DOI: 10.1016/J.Vaccine.2013.11.022 |
0.545 |
|
| 2013 |
Malherbe DC, Sanders RW, van Gils MJ, Park B, Gomes MM, Schuitemaker H, Barnett S, Haigwood NL. HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans. Plos One. 8: e75277. PMID 24040404 DOI: 10.1371/Journal.Pone.0075277 |
0.545 |
|
| 2013 |
Zhou Y, Bao R, Haigwood NL, Persidsky Y, Ho WZ. SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans. Retrovirology. 10: 89. PMID 23947613 DOI: 10.1186/1742-4690-10-89 |
0.488 |
|
| 2013 |
Jaworski JP, Kobie J, Brower Z, Malherbe DC, Landucci G, Sutton WF, Guo B, Reed JS, Leon EJ, Engelmann F, Zheng B, Legasse A, Park B, Dickerson M, Lewis AD, ... ... Haigwood NL, et al. Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques. Journal of Virology. 87: 10447-59. PMID 23885083 DOI: 10.1128/Jvi.00049-13 |
0.552 |
|
| 2012 |
Trovato M, Krebs SJ, Haigwood NL, De Berardinis P. Delivery strategies for novel vaccine formulations. World Journal of Virology. 1: 4-10. PMID 24175206 DOI: 10.5501/Wjv.V1.I1.4 |
0.392 |
|
| 2012 |
Pissani F, Malherbe DC, Robins H, DeFilippis VR, Park B, Sellhorn G, Stamatatos L, Overbaugh J, Haigwood NL. Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially. Vaccine. 30: 5519-26. PMID 22749601 DOI: 10.1016/J.Vaccine.2012.06.042 |
0.618 |
|
| 2012 |
Lifson JD, Haigwood NL. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones. Cold Spring Harbor Perspectives in Medicine. 2: a007310. PMID 22675663 DOI: 10.1101/Cshperspect.A007310 |
0.398 |
|
| 2012 |
Jaworski JP, Krebs SJ, Trovato M, Kovarik DN, Brower Z, Sutton WF, Waagmeester G, Sartorius R, D'Apice L, Caivano A, Doria-Rose NA, Malherbe D, Montefiori DC, Barnett S, De Berardinis P, ... Haigwood NL, et al. Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells. Plos One. 7: e31464. PMID 22359593 DOI: 10.1371/Journal.Pone.0031464 |
0.795 |
|
| 2012 |
Hessell AJ, Haigwood NL. Neutralizing antibodies and control of HIV: moves and countermoves. Current Hiv/Aids Reports. 9: 64-72. PMID 22203469 DOI: 10.1007/S11904-011-0105-5 |
0.577 |
|
| 2012 |
Malherbe D, Hessell A, Sather N, Guo B, Pandey S, Pissani F, Robins H, Kalams S, Stamatatos L, Haigwood N. Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P345 |
0.534 |
|
| 2012 |
Hessell A, Epson E, Moldt B, Rakasz E, Pandey S, Sutton W, Brower Z, Hirsch V, Burton, Haigwood N. Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques Retrovirology. 9: 204. DOI: 10.1186/1742-4690-9-S2-P204 |
0.511 |
|
| 2011 |
Malherbe DC, Doria-Rose NA, Misher L, Beckett T, Puryear WB, Schuman JT, Kraft Z, O'Malley J, Mori M, Srivastava I, Barnett S, Stamatatos L, Haigwood NL. Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies. Journal of Virology. 85: 5262-74. PMID 21430056 DOI: 10.1128/Jvi.02419-10 |
0.621 |
|
| 2010 |
Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, Kuller L, Anderson D, Landucci G, Richardson BA, Burton DR, Forthal DN, Haigwood NL. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nature Medicine. 16: 1117-9. PMID 20890292 DOI: 10.1038/Nm.2233 |
0.789 |
|
| 2010 |
Caivano A, Doria-Rose NA, Buelow B, Sartorius R, Trovato M, D'Apice L, Domingo GJ, Sutton WF, Haigwood NL, De Berardinis P. HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells. Virology. 407: 296-305. PMID 20850858 DOI: 10.1016/J.Virol.2010.08.026 |
0.497 |
|
| 2010 |
Haigwood NL, Yamamoto N, Iwamoto A. Host factors involved in the viral replication and particle formation could give a new insight into the innate immunity and may turn out to be a good target for therapeutic intervention. Introduction. Vaccine. 28: B1. PMID 20510736 DOI: 10.1016/J.Vaccine.2009.12.013 |
0.313 |
|
| 2009 |
Haigwood NL. Update on animal models for HIV research. European Journal of Immunology. 39: 1994-9. PMID 19672890 DOI: 10.1002/Eji.200939576 |
0.49 |
|
| 2009 |
Haigwood NL, Hirsch VM. Blocking and tackling HIV. Nature Medicine. 15: 841-2. PMID 19661984 DOI: 10.1038/Nm0809-841 |
0.561 |
|
| 2009 |
Provine NM, Puryear WB, Wu X, Overbaugh J, Haigwood NL. The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity. Journal of Virology. 83: 9002-7. PMID 19535443 DOI: 10.1128/Jvi.00423-09 |
0.483 |
|
| 2009 |
Farquhar C, Wamalwa D, Selig S, John-Stewart G, Mabuka J, Majiwa M, Sutton W, Haigwood N, Wariua G, Lohman-Payne B. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination. The Pediatric Infectious Disease Journal. 28: 295-9. PMID 19258919 DOI: 10.1097/Inf.0B013E3181903Ed3 |
0.463 |
|
| 2009 |
Ma ZM, Stone M, Piatak M, Schweighardt B, Haigwood NL, Montefiori D, Lifson JD, Busch MP, Miller CJ. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. Journal of Virology. 83: 3288-97. PMID 19129448 DOI: 10.1128/Jvi.02423-08 |
0.343 |
|
| 2009 |
Mahalanabis M, Jayaraman P, Miura T, Pereyra F, Chester EM, Richardson B, Walker B, Haigwood NL. Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers. Journal of Virology. 83: 662-72. PMID 18987151 DOI: 10.1128/Jvi.01328-08 |
0.563 |
|
| 2009 |
Malherbe D, Doria-Rose N, Misher L, Beckett T, Blay-Puryear W, Barnett S, Srivastava I, Richardson B, Stamatatos L, Haigwood N. P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P86 |
0.594 |
|
| 2008 |
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, et al. The use of nonhuman primate models in HIV vaccine development. Plos Medicine. 5: e173. PMID 18700814 DOI: 10.1371/Journal.Pmed.0050173 |
0.513 |
|
| 2007 |
Blish CA, Blay WM, Haigwood NL, Overbaugh J. Transmission of HIV-1 in the face of neutralizing antibodies. Current Hiv Research. 5: 578-87. PMID 18045114 DOI: 10.2174/157016207782418461 |
0.802 |
|
| 2007 |
Blay WM, Kasprzyk T, Misher L, Richardson BA, Haigwood NL. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. Journal of Virology. 81: 13037-49. PMID 17855534 DOI: 10.1128/Jvi.01215-07 |
0.803 |
|
| 2007 |
Kraft Z, Derby NR, McCaffrey RA, Niec R, Blay WM, Haigwood NL, Moysi E, Saunders CJ, Wrin T, Petropoulos CJ, McElrath MJ, Stamatatos L. Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies Journal of Virology. 81: 6402-6411. PMID 17392364 DOI: 10.1128/Jvi.00424-07 |
0.821 |
|
| 2007 |
Jayaraman P, Zhu T, Misher L, Mohan D, Kuller L, Polacino P, Richardson BA, Bielefeldt-Ohmann H, Anderson D, Hu SL, Haigwood NL. Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. Journal of Virology. 81: 822-34. PMID 17079310 DOI: 10.1128/Jvi.01759-06 |
0.531 |
|
| 2006 |
Haigwood NL. Insights into neutralizing antibodies and HIV envelope. Current Opinion in Hiv and Aids. 1: 301-8. PMID 19372825 DOI: 10.1097/01.Coh.0000232345.31156.Eb |
0.593 |
|
| 2006 |
Florese RH, Rompay KKAV, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M. Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmaC251 challenge Journal of Immunology. 177: 4028-4036. PMID 16951366 DOI: 10.4049/Jimmunol.177.6.4028 |
0.462 |
|
| 2006 |
Jayaraman P, Haigwood NL. Animal models for perinatal transmission of HIV-1. Frontiers in Bioscience : a Journal and Virtual Library. 11: 2828-44. PMID 16720355 DOI: 10.2741/2012 |
0.496 |
|
| 2006 |
Blay WM, Gnanakaran S, Foley B, Doria-Rose NA, Korber BT, Haigwood NL. Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. Journal of Virology. 80: 999-1014. PMID 16379001 DOI: 10.1128/Jvi.80.2.999-1014.2006 |
0.79 |
|
| 2006 |
Siman-Tov DD, Navon-Perry L, Haigwood NL, Gershoni JM. Differentiation of a passive vaccine and the humoral immune response toward infection: analysis of phage displayed peptides. Vaccine. 24: 607-12. PMID 16171907 DOI: 10.1016/J.Vaccine.2005.08.039 |
0.482 |
|
| 2005 |
Farquhar C, Nduati R, Haigwood N, Sutton W, Mbori-Ngacha D, Richardson B, John-Stewart G. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 494-7. PMID 16280707 DOI: 10.1097/01.Qai.0000168179.68781.95 |
0.525 |
|
| 2005 |
Mahalanabis M, Hirsch VM, Haigwood NL. Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing activity Journal of Medical Primatology. 34: 253-261. PMID 16128920 DOI: 10.1111/J.1600-0684.2005.00123.X |
0.594 |
|
| 2005 |
Doria-Rose NA, Learn GH, Rodrigo AG, Nickle DC, Li F, Mahalanabis M, Hensel MT, McLaughlin S, Edmonson PF, Montefiori D, Barnett SW, Haigwood NL, Mullins JI. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. Journal of Virology. 79: 11214-24. PMID 16103173 DOI: 10.1128/Jvi.79.17.11214-11224.2005 |
0.625 |
|
| 2005 |
Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, Morris L, Petropoulos CJ, Polonis VR, Sarzotti M, Montefiori DC. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. Journal of Virology. 79: 10103-7. PMID 16051803 DOI: 10.1128/Jvi.79.16.10103-10107.2005 |
0.551 |
|
| 2004 |
De Berardinis P, Haigwood NL. New recombinant vaccines based on the use of prokaryotic antigen-display systems. Expert Review of Vaccines. 3: 673-9. PMID 15606352 DOI: 10.1586/14760584.3.6.673 |
0.41 |
|
| 2004 |
Jayaraman P, Mohan D, Polacino P, Kuller L, Sheikh N, Bielefeldt-Ohmann H, Richardson B, Anderson D, Hu SL, Haigwood NL. Perinatal transmission of SHIV-SF162P3 in Macaca nemestrina. Journal of Medical Primatology. 33: 243-50. PMID 15525325 DOI: 10.1111/J.1600-0684.2004.00079.X |
0.361 |
|
| 2004 |
Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology. 14: 1229-1246. PMID 15175256 DOI: 10.1093/Glycob/Cwh106 |
0.785 |
|
| 2004 |
Mossman SP, Pierce CC, Watson AJ, Robertson MN, Montefiori DC, Kuller L, Richardson BA, Bradshaw JD, Munn RJ, Hu SL, Greenberg PD, Benveniste RE, Haigwood NL. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles. Aids Research and Human Retroviruses. 20: 425-34. PMID 15157361 DOI: 10.1089/088922204323048177 |
0.494 |
|
| 2004 |
Haigwood NL, Montefiori DC, Sutton WF, McClure J, Watson AJ, Voss G, Hirsch VM, Richardson BA, Letvin NL, Hu SL, Johnson PR. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. Journal of Virology. 78: 5983-95. PMID 15140996 DOI: 10.1128/Jvi.78.11.5983-5995.2004 |
0.637 |
|
| 2004 |
Safrit JT, Ruprecht R, Ferrantelli F, Xu W, Kitabwalla M, Van Rompay K, Marthas M, Haigwood N, Mascola JR, Luzuriaga K, Jones SA, Mathieson BJ, Newell ML. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 169-77. PMID 14722451 DOI: 10.1097/00126334-200402010-00012 |
0.433 |
|
| 2004 |
Doria-Rose NA, Ohlen C, Polacino P, Pierce CC, Hensel MT, Kuller L, Mulvania T, Anderson D, Greenberg PD, Hu S, Haigwood NL. Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge Journal of Virology. 78: 13396-13396. DOI: 10.1128/Jvi.78.23.13396.2004 |
0.419 |
|
| 2003 |
Haigwood NL, Stamatatos L. Role of neutralizing antibodies in HIV infection. Aids (London, England). 17: S67-71. PMID 15080182 DOI: 10.1097/00002030-200317004-00008 |
0.563 |
|
| 2003 |
Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, Buckler C, Plishka RJ, Buckler-White A, Martin MA. Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proceedings of the National Academy of Sciences of the United States of America. 100: 15131-6. PMID 14627745 DOI: 10.1073/Pnas.2436476100 |
0.597 |
|
| 2003 |
Doria-Rose NA, Ohlen C, Polacino P, Pierce CC, Hensel MT, Kuller L, Mulvania T, Anderson D, Greenberg PD, Hu SL, Haigwood NL. Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. Journal of Virology. 77: 11563-77. PMID 14557642 DOI: 10.1128/Jvi.77.21.11563-11577.2003 |
0.477 |
|
| 2003 |
Doria-Rose NA, Haigwood NL. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods (San Diego, Calif.). 31: 207-16. PMID 14511953 DOI: 10.1016/S1046-2023(03)00135-X |
0.383 |
|
| 2003 |
Doria-Rose NA, Pierce CC, Hensel MT, Sutton WF, Sheikh N, Polacino P, Kuller L, Zhu YD, Hu SL, Anderson D, Haigwood NL. Multigene DNA prime-boost vaccines for SHIV89.6P. Journal of Medical Primatology. 32: 218-28. PMID 14498982 DOI: 10.1034/J.1600-0684.2003.00028.X |
0.418 |
|
| 2002 |
Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. Journal of Virology. 76: 2123-30. PMID 11836389 DOI: 10.1128/Jvi.76.5.2123-2130.2002 |
0.55 |
|
| 2000 |
Zhu Y, Koo K, Bradshaw JD, Sutton WF, Kuller LR, Bucala R, Anderson D, Mossman SP, Villinger F, Haigwood NL. Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses. Journal of Medical Primatology. 29: 182-92. PMID 11085581 DOI: 10.1034/J.1600-0684.2000.290312.X |
0.354 |
|
| 1999 |
Mossman SP, Pierce CC, Robertson MN, Watson AJ, Montefiori DC, Rabin M, Kuller L, Thompson J, Lynch JB, Morton WR, Benveniste RE, Munn R, Hu SL, Greenberg P, Haigwood NL. Immunization against SIVmne in macaques using multigenic DNA vaccines. Journal of Medical Primatology. 28: 206-13. PMID 10593487 DOI: 10.1111/J.1600-0684.1999.Tb00271.X |
0.461 |
|
| 1999 |
Haigwood NL. Progress And Challenges In Therapies For Aids In Nonhuman Primate Models Journal of Medical Primatology. 28: 154-163. PMID 10593480 DOI: 10.1111/J.1600-0684.1999.Tb00264.X |
0.509 |
|
| 1999 |
Gicheru MM, Otsyula M, Spearman P, Graham BS, Miller CJ, Robinson HL, Haigwood NL, Montefiori DC. Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm) Journal of Medical Primatology. 28: 97-104. PMID 10475110 DOI: 10.1111/J.1600-0684.1999.Tb00257.X |
0.484 |
|
| 1999 |
Haigwood NL, Pierce CC, Robertson MN, Watson AJ, Montefiori DC, Rabin M, Lynch JB, Kuller L, Thompson J, Morton WR, Benveniste RE, Hu SL, Greenberg P, Mossman SP. Protection from pathogenic SIV challenge using multigenic DNA vaccines. Immunology Letters. 66: 183-8. PMID 10203053 DOI: 10.1016/S0165-2478(98)00156-4 |
0.457 |
|
| 1999 |
Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, Shibata R. Human Immunodeficiency Virus Type 1 Neutralizing Antibodies Accelerate Clearance Of Cell-Free Virions From Blood Plasma Nature Medicine. 5: 211-216. PMID 9930870 DOI: 10.1038/5576 |
0.477 |
|
| 1999 |
Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nature Medicine. 5: 204-210. PMID 9930869 DOI: 10.1038/5568 |
0.611 |
|
| 1998 |
Agosto M, Allan J, Benson C, Berger EA, Blumenthal R, Burton D, Clements J, Coffin J, Connor R, Cullen B, Desrosiers R, Dimitrov D, Doms R, Emerman M, Feinberg M, ... ... Haigwood N, et al. AIDS vaccine development. Science (New York, N.Y.). 280: 803, 804-5. PMID 9599148 DOI: 10.1126/Science.280.5365.803C |
0.465 |
|
| 1997 |
Watson A, McClure J, Ranchalis J, Scheibel M, Schmidt A, Kennedy B, Morton WR, Haigwood NL, Hu SL. Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. Aids Research and Human Retroviruses. 13: 1375-81. PMID 9359657 DOI: 10.1089/Aid.1997.13.1375 |
0.476 |
|
| 1997 |
Watson A, Ranchalis J, Travis B, McClure J, Sutton W, Johnson PR, Hu SL, Haigwood NL. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. Journal of Virology. 71: 284-90. PMID 8985348 DOI: 10.1128/Jvi.71.1.284-290.1997 |
0.444 |
|
| 1996 |
Murthy KK, Cobb EK, el-Amad Z, Ortega H, Hsueh FC, Satterfield W, Lee DR, Kalish ML, Haigwood NL, Kennedy RC, Steimer KS, Schultz A, Levy JA. Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. Aids Research and Human Retroviruses. 12: 1341-8. PMID 8891113 DOI: 10.1089/Aid.1996.12.1341 |
0.579 |
|
| 1996 |
Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu SL, Hirsch VM, Johnson PR. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunology Letters. 51: 107-14. PMID 8811353 DOI: 10.1016/0165-2478(96)02563-1 |
0.511 |
|
| 1995 |
el-Amad Z, Murthy KK, Higgins K, Cobb EK, Haigwood NL, Levy JA, Steimer KS. Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. Aids (London, England). 9: 1313-22. PMID 8605050 DOI: 10.1097/00002030-199512000-00003 |
0.572 |
|
| 1995 |
Silvera P, Flanagan B, Kent K, Rud E, Powell C, Corcoran T, Bruck C, Thiriart C, Haigwood NL, Stott EJ. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques. Aids Research and Human Retroviruses. 10: 1295-304. PMID 7848685 DOI: 10.1089/AID.1994.10.1295 |
0.439 |
|
| 1995 |
CHACKERIAN B, HAIGWOOD NL, OVERBAUGH J. Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates Virology. 213: 386-394. PMID 7491763 DOI: 10.1006/Viro.1995.0011 |
0.524 |
|
| 1994 |
Ahmad S, Lohman B, Marthas M, Giavedoni L, El-Amad Z, Haigwood NL, Scandella CJ, Gardner MB, Luciw PA, Yilma T. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus Aids Research and Human Retroviruses. 10: 195-204. PMID 8198872 DOI: 10.1089/Aid.1994.10.195 |
0.442 |
|
| 1993 |
Barbas CF, Collet TA, Amberg W, Roben P, Binley JM, Hoekstra D, Cababa D, Jones TM, Williamson RA, Pilkington GR, Haigwood NL, Cabezas E, Satterthwait AC, Sanz I, Burton DR. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries Journal of Molecular Biology. 230: 812-823. PMID 8478936 DOI: 10.1006/Jmbi.1993.1203 |
0.458 |
|
| 1993 |
Giavedoni LD, Flanelles V, Haigwood NL, Ahmad S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, Yilma TD. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection Journal of Virology. 67: 577-583. PMID 8416384 DOI: 10.1128/Jvi.67.1.577-583.1993 |
0.582 |
|
| 1993 |
Pulliam L, West D, Haigwood N, Swanson RA. HIV-1 envelope gp120 alters astrocytes in human brain cultures. Aids Research and Human Retroviruses. 9: 439-44. PMID 8318270 DOI: 10.1089/Aid.1993.9.439 |
0.481 |
|
| 1993 |
Scandella CJ, Kilpatrick J, Lidster W, Parker C, Moore JP, Moore GK, Mann KA, Brown P, Coates S, Chapman B, Masiarz FR, Steimer KS, Haigwood NL. Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development Aids Research and Human Retroviruses. 9: 1233-1244. PMID 8142140 DOI: 10.1089/Aid.1993.9.1233 |
0.563 |
|
| 1993 |
Müller S, Wang H, Silverman GJ, Bramlet G, Haigwood N, Köhler H. B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scandinavian Journal of Immunology. 38: 327-34. PMID 7692591 DOI: 10.1111/j.1365-3083.1993.tb01734.x |
0.512 |
|
| 1993 |
Hariharan K, Nara PL, Caralli VM, Norton FL, Haigwood N, Kang CY. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals. Journal of Virology. 67: 953-60. PMID 7678311 DOI: 10.1128/Jvi.67.2.953-960.1993 |
0.562 |
|
| 1993 |
Kliks SC, Shioda T, Haigwood NL, Levy JA. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 90: 11518-22. PMID 7505441 DOI: 10.1073/Pnas.90.24.11518 |
0.437 |
|
| 1993 |
Steimer KS, Haigwood NL. Immunization of primates with native, recombinant HIV-SF2 gp120 generates broadly effective neutralizing antibodies directed to conformational epitopes. Aids Research and Human Retroviruses. 8: 1391. PMID 1281658 DOI: 10.1089/AID.1992.8.1391 |
0.503 |
|
| 1993 |
Giavedoni LD, Planelles V, Haigwood NL, Ahmad S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, Yilma TD. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. Journal of Virology. 67: 577-583. DOI: 10.1128/jvi.67.1.577-583.1993 |
0.418 |
|
| 1992 |
Haigwood NL, Nara PL, Brooks E, Nest GAV, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. Journal of Virology. 66: 172-182. PMID 1727480 DOI: 10.1128/Jvi.66.1.172-182.1992 |
0.62 |
|
| 1992 |
Johnson PR, Montefiori DC, Goldstein S, Hamm TE, Zhou J, Kltov S, Haigwood NL, Mlsher L, London WT, Gerin JL, Allison A, Purcell RH, Chancck RM, Hirsch VM. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge Proceedings of the National Academy of Sciences of the United States of America. 89: 2175-2179. PMID 1549578 DOI: 10.1073/Pnas.89.6.2175 |
0.516 |
|
| 1992 |
Haigwood NL, Misher L, Chin SM, Blair M, Planelles V, Scandella CJ, Steimer KS, Gardner MB, Yilma T, Hirsch VM. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques Journal of Medical Primatology. 21: 82-90. PMID 1433271 DOI: 10.1111/J.1600-0684.1992.Tb00572.X |
0.595 |
|
| 1992 |
Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly - RP, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis Journal of Experimental Medicine. 176: 1099-1106. PMID 1402655 DOI: 10.1084/Jem.176.4.1099 |
0.49 |
|
| 1992 |
Takeda A, Robinson JE, Ho DD, Debouck C, Haigwood NL, Ennis FA. Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120. The Journal of Clinical Investigation. 89: 1952-7. PMID 1376330 DOI: 10.1172/JCI115802 |
0.553 |
|
| 1992 |
Stephens DM, Eichberg JW, Haigwood NL, Steimer KS, Davis D, Lachmann PJ. Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine. The Journal of General Virology. 73: 1099-106. PMID 1375277 DOI: 10.1099/0022-1317-73-5-1099 |
0.494 |
|
| 1991 |
Kang CY, Nara P, Chamat S, Caralli V, Ryskamp T, Haigwood N, Newman R, Köhler H. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proceedings of the National Academy of Sciences of the United States of America. 88: 6171-6175. PMID 2068099 DOI: 10.1073/Pnas.88.14.6171 |
0.515 |
|
| 1991 |
Back NKT, Haigwood NL, Wolf FD, Jongh BMD, Goudsmit J. Antibody Reactivity to Deletion Mutants of the HIV-1 SF2 Envelope Intervirology. 32: 160-172. PMID 2040587 DOI: 10.1159/000150196 |
0.539 |
|
| 1991 |
Planelles V, Haigwood NL, Marthas ML, Mann KA, Scandella C, Lidster WD, Shuster JR, Van Kuyk R, Marx PA, Gardner MB, Luciw PA. Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells Aids Research and Human Retroviruses. 7: 889-898. PMID 1760229 DOI: 10.1089/Aid.1991.7.889 |
0.433 |
|
| 1991 |
Steimer KS, Scandella CJ, Skiles PV, Haigwood NL. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science. 254: 105-108. PMID 1718036 DOI: 10.1126/Science.1718036 |
0.634 |
|
| 1991 |
Chapman BS, Thayer RM, Vincent KA, Haigwood NL. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells Nucleic Acids Research. 19: 3979-3986. PMID 1650459 DOI: 10.1093/Nar/19.14.3979 |
0.34 |
|
| 1990 |
Haigwood NL, Shuster JR, Moore GK, Lee H, Skiles PV, Higgins KW, Barr PJ, George-Nascimento C, Steimer KS. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. Aids Research and Human Retroviruses. 6: 855-869. PMID 2390335 DOI: 10.1089/Aid.1990.6.855 |
0.589 |
|
| 1990 |
Abrignani S, Montagna D, Jeannet M, Wintsch J, Haigwood NL, Shuster JR, Steimer KS, Cruchaud A, Staehelin T. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. Proceedings of the National Academy of Sciences of the United States of America. 87: 6136-6140. PMID 1696717 DOI: 10.1073/Pnas.87.16.6136 |
0.514 |
|
| 1990 |
Morrow WJ, Gaston I, Anderson T, Haigwood N, McGrath MS, Rosen J, Steimer KS. Anti-idiotypic antisera raised against monoclonal antibody specific for a p24 gag region epitope detects a common interspecies idiotype associated with anti-HIV responses. Viral Immunology. 3: 99-109. PMID 1694432 DOI: 10.1089/VIM.1990.3.99 |
0.494 |
|
| Show low-probability matches. |